Synergy CHC Corp.
SNYR- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001562733
No open-market purchases or sales by Synergy CHC Corp. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $133.1K in total; no superinvestor holds it.
Other share classesSNYRQ
Holders of 5% or more of SNYR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Synergy CHC Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Knight Therapeutics Inc | 13G/A | 19.90%1.91M shares | +2.87 ppfrom 17.03% | Mar 20, 20252 filings | Jun 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Synergy CHC Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 13, 20254:06 PM ET | Knight Therapeutics Inc | 13G/A | 19.90%1.91M shares | +2.87 ppfrom 17.03% | Jun 11, 2025 | SEC |
| Mar 20, 20254:01 PM ET | Knight Therapeutics Inc | 13G | 17.03%1.48M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Synergy CHC Corp. shares.
No Form 144 notices for Synergy CHC Corp. are on file.